Novolog Related Clinical Trials
A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients [Completed]
Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids [Completed]
Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes [Completed]
Bioequivalence of Two NovoLog� Formulations in Subjects With Type 1 Diabetes [Completed]
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children [Completed]
Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers [Completed]
Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart [Recruiting]
Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy [Terminated]
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy [Completed]
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin [Completed]
Comparison of Insulins Aspart and Lispro in Insulin Pumps [Completed]
Insulin Glargine "All to Target" Trial [Completed]
Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart [Completed]
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs [Completed]
Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes [Not yet recruiting]
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes [Completed]
Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes [Completed]
Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes [Completed]
A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes [Completed]
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs [Completed]
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen� in Insulin Naive Subjects With Type 2 Diabetes [Completed]
Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects [Completed]
Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA [Completed]
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin [Completed]
Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) [Completed]
Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial [Completed]
Comparison of Two Formulations of Biphasic Insulin Aspart 70 [Completed]
Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care [Withdrawn]
Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes [Completed]
Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses [Completed]
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use [Completed]
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics [Completed]
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes [Completed]
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects [Completed]
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects [Completed]
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects [Completed]
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects [Completed]
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes [Completed]
NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes [Completed]
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes [Completed]
Observational Study of NovoMix� 50 for Treatment of Type 2 Diabetics for 12 Months [Completed]
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes [Completed]
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes [Completed]
Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes [Completed]
Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients [Completed]
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes [Completed]
Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin [Completed]
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents [Completed]
Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes [Completed]
A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes [Completed]
Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects [Completed]
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study [Recruiting]
Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes [Completed]
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use [Completed]
Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication [Completed]
Changes of the Infusion Rate in Insulin Pump Treatment [Completed]
Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes [Completed]
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid� Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes [Not yet recruiting]
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes [Completed]
Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes [Completed]
Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes [Completed]
Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes [Completed]
Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes [Completed]
Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes [Completed]
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes [Completed]
An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment [Completed]
Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen® [Completed]
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus [Completed]
Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins [Completed]
Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30 [Completed]
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes [Completed]
Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus [Completed]
Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers [Completed]
Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes [Completed]
Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 [Completed]
Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes [Completed]
Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers [Completed]
Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes [Completed]
A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes [Completed]
Insulin by Jet-injection for Hyperglycemia in Diabetes [Completed]
A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects [Completed]
A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients [Not yet recruiting]
Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes [Completed]
Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) [Completed]
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus [Completed]
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects [Completed]
Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes [Completed]
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects [Completed]
Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process [Completed]
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. [Completed]
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma [Terminated]
|
